AKESOgen, a leader in personalized medicine and genomics, has partnered with Targos and the National Society of Histotechnology to create and assemble an inaugural course on In-situ Hybridization, Microarray & Next-Generation Sequencing in Clinical Diagnostics. The course will be held at the Emory conference center on Oct 26th-28th, 2015. Please click the link below to view the agenda. Additionally, the course will provide CEU credits.
AKESOgen is an integrated genomics and pharmacogenetics company providing biorepository services and high-throughput, biomarker profiling and genomics analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the clinical and R&D market to CLIA standards. A private company based in Atlanta, GA, AKESOgen is a genomics contract research organization that services the academic, pharmaceutical, biotechnology, clinical testing and government sectors. AKESOgen provides expertise in biobanking, assay development and all ancillary services in a purpose-built facility. For more information, visit www.akesogen.com.
About the National Society of Histotechnologists
NSH is the premier source of learning, knowledge and future-oriented research for histology professionals. Attendance provides resources, education, ideas and advocacy to enhance the performance in the laboratory and ultimately the best patient care.